| Description |
1 online resource |
| Summary |
Par-4 is a naturally occurring tumor suppressor. Studies have indicated that overexpression of Par-4 selectively induces apoptosis in cancer cells while leaving normal, health, cells unaffected. Mechanisms contributing to this cancer-selective action of Par-4 have been associated with PKA activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. On the other hand, endogenous Par-4 sensitizes cells to the action of a broad range of apoptotic inducers acting via the extrinsic and intrinsic pathways. A number of binding partners of Par-4 have been identified and shown to regulate Par-4 function in cancer and other diseases, such as Alzheimer's and major depression. Recent studies have recognized a number of natural products, dietary supplements, synthetic molecules and FDA-approved drugs that induce the secretion of Par-4 protein to cause apoptosis in primary or metastatic tumors, one of which is in clinical trials. More than 50 different laboratories worldwide are involved in Par-4 based research of this unique protein that has progressed from the bench to clinical trials. This second, companion volume will provide a comprehensive overview of Par-4's role in cancer and other diseases. Chapters are written by leading researchers, and will be useful for a broad audience across the scientific community, particularly students and trainees, who are the next generation of scientists and clinicians to participate in new studies and discoveries on Par-4 |
| Notes |
Includes index |
|
Online resource; title from PDF title page (SpringerLink, viewed January 13, 2022) |
| Subject |
Tumor suppressor proteins.
|
|
Cancer cells.
|
|
Tumor Suppressor Proteins
|
|
Cancer cells
|
|
Tumor suppressor proteins
|
|
Tumors.
|
| Genre/Form |
Llibres electrònics.
|
| Form |
Electronic book
|
| Author |
Rangnekar, Vivek, editor.
|
| ISBN |
9783030805586 |
|
3030805581 |
|
